User:Intentionally Left Blank/CDRD

Centre for Drug Research and Development (CDRD)
Founded in 2007, the Centre for Drug Research and Development (CDRD) is a non-profit organization that combines an academic infrastructure and a commercialization arm in a hybrid structure. The aim of the CDRD is to develop the commercial potential of promising new drug discoveries from health science investigators. CDRD is a joint initiative of BC’s research institutions (the Affiliated Institutions, which includes the University of British Columbia, Simon Fraser University, the BC Cancer Agency, the University of Victoria, the University of Northern BC, Providence Healthcare, Vancouver Coastal Health, Provincial Health Services Association) in partnership with the Provincial Government and Industry.

Over 250 life science researchers from all life science research institutions in British Columbia are members of CDRD and over 200 potential drug technologies have been identified. CDRD has established and equipped five divisions that reflect the drug development process including drug target identification, drug screening, drug design and synthesis (medicinal chemistry), drug formulation and delivery and drug evaluation (in vivo efficacy and toxicity). CDRD provides investigators access to both the labs and drug development experts with experience in bringing therapeutics to market. It also provides a new research and training model that will broaden the pool of biotech entrepreneurs working on drug discovery and development. CDRD will initially concentrate its expertise in three therapeutic areas: cancer, infectious disease and neurological disorders. Natalie Dakers is CDRD’s Chief Executive Officer and Pieter Cullis is CDRD’s Scientific Director.

CDRD in the News

 * Pfizer Canada Invests in Centre for Drug Research and Development to Accelerate the Drug Development Process
 * Centre for Drug Research and Development Receives $15 Million from Government of Canada
 * Medical drug research and development supported by Canada’s New Government
 * From The Lab Bench To Bedside: Guiding Researchers Across The Valley of Death -- Green Light for Centre for Drug Research and Development
 * Centre for Drug Research and Development Receives Additional $8 Million in Funding from the Province of British Columbia

CDRD Founders

 * Terry Allen, University of Alberta, (Sequus)
 * Helen Burt, UBC Professor (Angiotech Research Chair)
 * Pieter Cullis, Scientific Director, CDRD (Co-founder, former CSO, Inex)
 * Natalie Dakers, CEO, CDRD (Co-founder, former CEO, Neuromed)
 * David Dolphin, Chairman, CDRD and UBC Professor
 * Bob Hancock, UBC Professor, (Co-founder, Migenix & Inimex)
 * Angus Livingstone, UBC, Managing Director, University Industry Liaison Office
 * Mario Pinto, VP Research, Simon Fraser University
 * Michel Roberge, Division Head, CDRD, UBC Professor (Canadian Chemical Biology Network)
 * Robert Sindelar, Division Co-Head, CDRD, Dean, Pharmaceutical Sciences, UBC
 * Stephen Withers, UBC Professor (Protein Engineering NCE)

Affiliations

 * University of British Columbia
 * Simon Fraser University
 * University of Northern British Columbia
 * University of Victoria
 * BC Cancer Agency
 * Providence Health Care
 * Vancouver Coastal Health
 * Provincial Health Services Authority
 * Children's & Women's Health Centre of British Columbia (C&W)
 * Canada Foundation for Innovation
 * Centres of Excellence for Commercialization and Research (CECRs)
 * Michael Smith Foundation for Health Research
 * Canadian Institutes for Health Research
 * LifeSciences BC

CDRD in the News

 * Pfizer Canada Invests in Centre for Drug Research and Development to Accelerate the Drug Development Process
 * Centre for Drug Research and Development Receives $15 Million from Government of Canada
 * Medical drug research and development supported by Canada’s New Government
 * From The Lab Bench To Bedside: Guiding Researchers Across The Valley of Death -- Green Light for Centre for Drug Research and Development
 * Centre for Drug Research and Development Receives Additional $8 Million in Funding from the Province of British Columbia

CDRD Founders

 * Terry Allen, University of Alberta, (Sequus)
 * Helen Burt, UBC Professor (Angiotech Research Chair)
 * Pieter Cullis, Scientific Director, CDRD (Co-founder, former CSO, Inex)
 * Natalie Dakers, CEO, CDRD (Co-founder, former CEO, Neuromed)
 * David Dolphin, Chairman, CDRD and UBC Professor
 * Bob Hancock, UBC Professor, (Co-founder, Migenix & Inimex)
 * Angus Livingstone, UBC, Managing Director, University Industry Liaison Office
 * Mario Pinto, VP Research, Simon Fraser University
 * Michel Roberge, Division Head, CDRD, UBC Professor (Canadian Chemical Biology Network)
 * Robert Sindelar, Division Co-Head, CDRD, Dean, Pharmaceutical Sciences, UBC
 * Stephen Withers, UBC Professor (Protein Engineering NCE)

Affiliations

 * University of British Columbia
 * Simon Fraser University
 * University of Northern British Columbia
 * University of Victoria
 * BC Cancer Agency
 * Providence Health Care
 * Vancouver Coastal Health
 * Provincial Health Services Authority
 * Children's & Women's Health Centre of British Columbia (C&W)
 * Canada Foundation for Innovation
 * Centres of Excellence for Commercialization and Research (CECRs)
 * Michael Smith Foundation for Health Research
 * Canadian Institutes for Health Research
 * LifeSciences BC